Wolf–Hirschhorn syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Wolf–Hirschhorn syndrome | |
|---|---|
| |
| Synonyms | 4p deletion syndrome, Pitt-Rogers-Danks syndrome, Pitt syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Growth delay, intellectual disability, seizures, distinct facial features |
| Complications | N/A |
| Onset | Prenatal |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation (deletion of part of chromosome 4) |
| Risks | |
| Diagnosis | Genetic testing, karyotype |
| Differential diagnosis | Cri du chat syndrome, Angelman syndrome, Rett syndrome |
| Prevention | |
| Treatment | Supportive care, seizure management, physical therapy |
| Medication | Anticonvulsants |
| Prognosis | Variable |
| Frequency | 1 in 50,000 births |
| Deaths | |
Wolf–Hirschhorn syndrome (WHS) is a genetic disorder characterized by a distinctive facial appearance, delayed growth and development, intellectual disability, and seizures. It is caused by a deletion of genetic material near the end of the short (p) arm of chromosome 4 (4p16.3).
Genetics[edit]
Wolf–Hirschhorn syndrome is a result of a chromosomal deletion on the short arm of chromosome 4. The size of the deletion varies among affected individuals, and larger deletions tend to result in more severe symptoms. The critical region for WHS is located at 4p16.3, which includes several genes that are important for normal development.
Clinical Features[edit]
Individuals with Wolf–Hirschhorn syndrome often have a characteristic "Greek warrior helmet" facial appearance, which includes a broad, flat nasal bridge and a high forehead. Other common features include:
- Microcephaly
- Hypertelorism (widely spaced eyes)
- Epicanthal folds
- Micrognathia (small jaw)
- Cleft lip and/or palate
Developmental and Intellectual Disabilities[edit]
Children with WHS typically experience significant developmental delays and intellectual disabilities. Motor skills such as sitting, standing, and walking are often delayed, and speech development is usually limited. Early intervention and special education programs can help improve outcomes for these children.
Seizures[edit]
Seizures are a common feature of Wolf–Hirschhorn syndrome, occurring in a majority of affected individuals. These seizures can vary in type and severity, and they often begin in infancy or early childhood. Management of seizures typically involves antiepileptic drugs and regular monitoring by a healthcare professional.
Diagnosis[edit]
Diagnosis of Wolf–Hirschhorn syndrome is based on clinical features and confirmed by genetic testing. Karyotyping and fluorescence in situ hybridization (FISH) can be used to detect the chromosomal deletion. More recently, microarray analysis has become a common method for diagnosing WHS, as it can detect smaller deletions that may not be visible with traditional karyotyping.
Management[edit]
There is no cure for Wolf–Hirschhorn syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include:
- Physical therapy to improve motor skills
- Speech therapy to enhance communication abilities
- Occupational therapy to assist with daily living skills
- Anticonvulsant medications to control seizures
Prognosis[edit]
The prognosis for individuals with Wolf–Hirschhorn syndrome varies depending on the severity of the condition and the presence of associated health issues. With appropriate medical care and support, many individuals with WHS can lead fulfilling lives.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
